Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...
Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...
The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Harrow's relaunch of Triesence, a preservative-free corticosteroid, is revolutionizing ophthalmology with safer and more ...
The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...
The U.S. Food and Drug Administration on Wednesday approved Mesoblast's cell therapy for treating a type of complication that ...
Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...
Verywell Health on MSN6d
Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains DifficultOver half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access the drugs.
The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...
Viatris' generic of Symbicort (budesonide and formoterol fumarate dihydrate) – developed by Viatris in collaboration with 3M spin-off company Kindeva Drug Delivery and called Breyna – has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback